Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis

BACKGROUND: Benralizumab is effective in severe eosinophilic asthma (SEA), but suboptimal responses are observed in some patients. Although several factors have been associated with benralizumab response, no cluster analysis has yet been undertaken to identify different responsiveness sub‐phenotypes...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Bona, Danilo, Crimi, Claudia, D’Uggento, Angela Maria, Benfante, Alida, Caiaffa, Maria Filomena, Calabrese, Cecilia, Campisi, Raffaele, Carpagnano, Giovanna Elisiana, Ciotta, Domenico, D'Amato, Maria, Pelaia, Corrado, Pelaia, Girolamo, Pellegrino, Simona, Scichilone, Nicola, Scioscia, Giulia, Ribecco, Nunziata, Spadaro, Giuseppe, Valenti, Giuseppe, Vatrella, Alessandro, Crimi, Nunzio, Macchia, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293293/
https://www.ncbi.nlm.nih.gov/pubmed/34608696
http://dx.doi.org/10.1111/cea.14026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293293/
https://www.ncbi.nlm.nih.gov/pubmed/34608696
http://dx.doi.org/10.1111/cea.14026

Ejemplares similares